T.Man Pharmaceutical PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	2,354	2,213	1,972	2,017	1,260	895.52
Other Revenue	22.03	13.35	7.81	8.05	3.43	5.26
Revenue	2,376	2,226	1,980	2,025	1,263	900.78
Revenue Growth (YoY)	8.17%	12.42%	-2.20%	60.26%	40.25%	-
Cost of Revenue	1,232	1,133	1,003	923.57	861.26	572.32
Gross Profit	1,144	1,093	976.84	1,101	402.08	328.46
Selling, General & Admin	577.3	546.65	496.43	452.32	313.35	248.35
Operating Expenses	582.38	543.35	451.8	492.88	321.07	254.23
Operating Income	561.85	549.98	525.04	608.21	81.01	74.23
Interest Expense	-32.62	-18.63	-14.85	-16.98	-7.18	-9.09
Pretax Income	529.24	531.36	510.19	591.23	73.83	65.15
Income Tax Expense	79.85	80.65	79.1	118.71	17.44	5.25
Earnings From Continuing Operations	449.38	450.7	431.09	472.52	56.39	59.89
Minority Interest in Earnings	-0	-0	-0	-	-	-
Net Income	449.38	450.7	431.09	472.52	56.39	59.89
Net Income to Common	449.38	450.7	431.09	472.52	56.39	59.89
Net Income Growth	3.72%	4.55%	-8.77%	737.91%	-5.84%	-
Shares Outstanding (Basic)	397	343	275	250	72	67
Shares Outstanding (Diluted)	397	343	275	250	72	67
Shares Change (YoY)	25.15%	24.68%	10.30%	246.21%	8.20%	-
EPS (Basic)	1.13	1.31	1.56	1.89	0.78	0.90
EPS (Diluted)	1.13	1.31	1.56	1.89	0.78	0.90
EPS Growth	-17.12%	-16.14%	-17.29%	142.02%	-12.98%	-
Free Cash Flow	305.81	345.71	62.15	289.02	196.49	128.83
Free Cash Flow Per Share	0.77	1.01	0.23	1.16	2.72	1.93
Dividend Per Share	-	0.200	0.036	-	-	-
Dividend Growth	-	455.56%	-	-	-	-
Gross Margin	48.16%	49.12%	49.33%	54.38%	31.83%	36.46%
Operating Margin	23.65%	24.71%	26.52%	30.04%	6.41%	8.24%
Profit Margin	18.91%	20.25%	21.77%	23.34%	4.46%	6.65%
Free Cash Flow Margin	12.87%	15.53%	3.14%	14.27%	15.55%	14.30%
EBITDA	671.88	645.11	611.56	678.68	148.29	143.51
EBITDA Margin	28.28%	28.98%	30.89%	33.52%	11.74%	15.93%
D&A For EBITDA	110.03	95.12	86.52	70.48	67.28	69.28
EBIT	561.85	549.98	525.04	608.21	81.01	74.23
EBIT Margin	23.65%	24.71%	26.52%	30.04%	6.41%	8.24%
Effective Tax Rate	15.09%	15.18%	15.50%	20.08%	23.62%	8.06%
Revenue as Reported	2,376	2,226	1,980	2,025	1,263	900.78
Advertising Expenses	-	113	97	89	52	34

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.